Research Output | Dar Al-hikmah Library | IIUM Only
Direct oral anticoagulants (DOACs), such as dabigatran and rivaroxaban, have in the past decade replaced vitamin k antagonists (VKAs), such as warfarin, as standard treatment for thrombosis prophylaxis and stroke prevention in patients with atrial fibrillation (AF). Adherence to DOACs is crucial to optimise clinical outcomes in patients with AF. Th